1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Regulatory T Cell Depletion: new trials by email Literature Review of Regulatory T Cell Depletion trials Research Report on Regulatory T Cell Depletion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion T-reg depleted DLI - Hematological Malignancies, Regulatory T Cell Depletion | Phase 1 / Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 27 | 2024-03-01 | 2024-02-14 |
| Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells T-reg depleted DLI, Standard DLI - Hematological Malignancies, Regulatory T Cell Depletion | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 52 | 2018-02-22 | 2023-12-18 |
Hematologic Neoplasms (2) · Recurrence (2)
Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Assistance Publique - Hôpitaux de Paris (2)
France (1)